<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" dstore:dataset="usaid-998" dstore:index="3123" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:dstore="http://d-portal.org/xmlns/dstore" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:usg="https://explorer.usaid.gov">
  <iati-identifier>US-GOV-1-7200GH21IO00002</iati-identifier>
  <reporting-org ref="US-GOV-1" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">COVAX Advance Market Commitment (AMC) Contribution</narrative>
  </title>
  <description>
   <narrative xml:lang="EN">The U.S. contribution is to the COVAX Advance Market Commitment (AMC), which enables donor-funded access to safe and effective vaccines for 92 low- and middle-income economies. COVAX aspires to distribute enough doses to cover at least 20% of AMC country populations.  Vaccines made possible through this contribution will be distributed as determined by the World Health Organization within the COVID-19 Vaccine Global Access Facility (COVAX) framework, a multilateral mechanism which facilitates global access to COVID-19 vaccines.</narrative>
  </description>
  <participating-org ref="US-GOV-11" role="1" type="10">
   <narrative xml:lang="EN">Department of State</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="2" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="3" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <participating-org role="4" type="40">
   <narrative xml:lang="EN">Global Alliance for Vaccines and Immunization</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-03-05" type="1"></activity-date>
  <activity-date iso-date="2021-03-05" type="2"></activity-date>
  <activity-date iso-date="2021-09-30" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN"></narrative>
   </person-name>
   <telephone>+1 (202) 712 4810</telephone>
   <email>aidtransparency@usaid.gov</email>
   <website>https://www.usaid.gov/who-we-are/organization/bureaus/bureau-global-health</website>
   <mailing-address>
    <narrative xml:lang="EN">1300 Pennsylvania Ave NW, Washington DC 20004</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction ref="9DE2F43A357B">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-03-31"></transaction-date>
   <value currency="USD" value-date="2021-03-31">2000000000</value>
   <description>
    <narrative xml:lang="EN">GLIDE: EP-2020-000012-001 (COVID-19)</narrative>
   </description>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3006" vocabulary="99">
    <narrative xml:lang="EN">Maternal and Child Health</narrative>
   </sector>
   <recipient-region code="998"></recipient-region>
   <usg:humanitarian-scope code="EP-2020-000012-001"></usg:humanitarian-scope>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2021" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="9DE2F43A357B">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-31"></transaction-date>
   <value currency="USD" value-date="2021-03-31">2000000000</value>
   <description>
    <narrative xml:lang="EN">GLIDE: EP-2020-000012-001 (COVID-19)</narrative>
   </description>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12250" vocabulary="1">
    <narrative xml:lang="EN">Infectious disease control</narrative>
   </sector>
   <sector code="3006" vocabulary="99">
    <narrative xml:lang="EN">Maternal and Child Health</narrative>
   </sector>
   <recipient-region code="998"></recipient-region>
   <usg:humanitarian-scope code="EP-2020-000012-001"></usg:humanitarian-scope>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2021" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <conditions attached="0"></conditions>
  <usg:duns-number>
   <narrative>483451832</narrative>
  </usg:duns-number>
  <usg:mechanism-signing-date iso-date="2021-03-05"></usg:mechanism-signing-date>
  <usg:state-location>
   <narrative>Worldwide</narrative>
  </usg:state-location>
  <usg:tec1>
   <narrative>2000000000.00</narrative>
  </usg:tec1>
 </iati-activity>
</iati-activities>
